Stockreport

Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences

Sionna Therapeutics, Inc.  (SION) 
PDF WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize th [Read more]